MLTX EPS Estimates
MoonLake Immunotherapeutics
$10.58
-$0.19(-1.76%)
40
Overall
60
Value
36
Tech
26
Quality
Market Cap
$916.60M
Volume
3.72M
52W Range
$8.18 - $23.29
Target Price
$33.46
MLTX EPS estimates: the consensus estimate for MoonLake Immunotherapeutics's current fiscal year is -$3.34 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MLTX EPS Estimates
- EPS estimate, current quarter
- $-0.77
- EPS estimate, next quarter
- $-0.81
- EPS estimate, current year
- $-3.34
- EPS estimate, next year
- $-3.41
- EPS growth, 3-year
- -27.58%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.53 |
| 2024 | $-1.89 |
| 2023 | $-0.73 |
| 2022 | $-1.70 |
| 2021 | $-0.31 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLTX | $10.58 | -1.8% | 3.72M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MoonLake Immunotherapeutics Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW